Dishman Carbogen Amcis share price today

Dishman Carbogen Amcis Ltd's share price was ₹154.81 at the close on 4 November 2026. It has been falling for 41 weeks. That is 15.9% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹136 and ₹258, and at that close it sat 15% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Dishman Carbogen Amcis Ltd is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 7 weeks running.

Over the last 9.1 years the share price moved −54% while the NIFTY 500 moved +157%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 18 September 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

One change stood out: lowest operating margin in 8 quarters.

1. Lowest operating margin in 8 quarters

   Operating margin was 9% in the June 2026 quarter, against 20% a year earlier.

   Why: Margins fell because some customer shipments were delayed, so revenue was lower while costs stayed mostly fixed.

   Next results: check whether the delayed contract manufacturing shipments show up in the second half and lift that business's revenue.

   From the earnings call on 17 Aug 2026.

For April to June 2026 (the quarter ended 30 June 2026), Dishman Carbogen Amcis reported revenue of ₹678 crore, down 4.2% from ₹708 crore a year earlier, and a loss of ₹58.0 crore, down 352.2% from ₹23.0 crore.

Dishman Carbogen Amcis results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Dishman Carbogen Amcis' management discussed these results on a call held on 17 August 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Dishman Carbogen Amcis closed at ₹154.81 on 4 November 2026, down 37.8% from ₹248.85 a year earlier (7 November 2025) and down 27.2% over five years. Its highest weekly close since September 2017 was ₹383.00 on 25 January 2018.

Dishman Carbogen Amcis share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

480 weekly closes from 22 September 2017 to 4 November 2026.

4 Nov 2026: Dishman Carbogen Amcis closed at ₹154.81, up 6.8% on the week and up 3.0% on the month. 17 Aug 2026: Dishman Carbogen Amcis held its results call for April to June 2026. Management guided: FY27 group revenue: single-digit growth; operating margin similar to last year, potentially higher.

Earlier

• Results for April to June 2026: Revenue down 4.2% and profit down 352.2% on a year earlier.

Dishman Carbogen Amcis has paid no dividend on the NSE since 1 April 2021, the start of the period we checked.

Not in its latest year. Dishman Carbogen Amcis Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 1 of its last 11 reported years, so there is a history but no current dividend.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 17 August 2026, Dishman Carbogen Amcis' management guided: FY27 group revenue: single-digit growth; operating margin similar to last year, potentially higher.

“We do expect single-digit growth in revenue, and as far as the EBITDA margin is concerned, it should be similar to what we did last year. It could be a little bit higher, but that is more or less the guidance.”Harshil Dalal, on the call for April to June 2026

What management guided

• FY28-FY29 group revenue: above 10% on a year earlier, supported by India, Swiss CDMO and French operations.
• FY28-FY29 group operating margin: closer to 25-26%, supported by India and CDMO growth.
• FY27 India revenue: up 30-35% on a year earlier; operating margin: close to 10%.
• First Switzerland-to-Bavla transfer to complete within FY27.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 17 August 2026.

When Dishman Carbogen Amcis reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Deferred CDMO order recognition - check whether latter-half shipments reverse the segment's Q1 revenue shortfall.

Dishman Carbogen Amcis is on one of our India lists: Pharma stocks.

Dishman Carbogen Amcis Ltd posted a net loss of ₹58.0 Cr in the Jun 2026 quarter. Full-year FY26 profit was ₹97.0 Cr. Over 15 years profit has grown 1.3% a year on average. That loss is 8.6% of the quarter's revenue. The same quarter a year earlier earned ₹23.0 Cr. 6 of the last 12 reported quarters were loss-making.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

Jun 2026 profit was −₹58.0 Cr, −352.2% on a year earlier. For the full year, FY26 profit was ₹97.0 Cr (+3,133.3% on the year before).

Why profit moved: revenue changed −4.2% on a year earlier and the margin moved −11.0 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed −166.0% and revenue +0.8%. Profit is growing slower than sales: rising costs are taking part of the growth.

Dishman Carbogen Amcis Ltd reported ₹678 Cr of revenue in the Jun 2026 quarter, −4.2% on the same quarter a year earlier. Over 15 years it has grown 7.2% a year on average. The last full year, FY26, came in at ₹2,932 Cr. The last four reported quarters add to ₹2,902 Cr.

Revenue is everything the company billed its customers in the period.

FY26 revenue was ₹2,932 Cr, +8.1% on the year before.

Recent pace: the last four quarters grew +0.8% on average, against 7.2% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +0.2%, against +9.6% a year over the last 8 quarters (rolling over).

Dishman Carbogen Amcis Ltd's operating margin was 9.0% in the Jun 2026 quarter, 11.0 percentage points lower than the same quarter a year ago. Across 11 years it has been between 11.0% and 27.0%. The latest quarter is below every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −11.0 percentage points on the year while gross margin changed −3.0 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

Over the last 3 years, 1,031% of Dishman Carbogen Amcis Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹491 Cr of operating cash against ₹97.0 Cr of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

After ₹1,463 Cr of spending on assets, free cash was −₹972 Cr: it spent more than its operations brought in.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 1,031% of profit came in as cash: the cash cycle got 455 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives.

What to look at next: the bigger use of cash is spending on new assets, at 2.5× depreciation over three years. The next section checks what that spending is building.

Dishman Carbogen Amcis Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 805 days in FY26, up from 350 days in FY21. It spent ₹2,359 Cr on assets over the last 3 years. Customers take 84 days to pay, and stock sits for 910 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹2,932 Cr, each day of that cycle ties up about ₹8.0 Cr, so roughly ₹6,466 Cr is tied up in the business at any time.

FY26: customers took 84 days to pay and stock sat for 910 days, about 29.9 months of sales sitting as stock, for a full cycle of 805 days, longer than FY21's 350.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 910 days. Customers pay about 84 days after that. Suppliers are paid at 189 days. Together that makes the 805-day cycle.

Spending on assets: ₹2,359 Cr over the last 3 years, against ₹944 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹570 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Dishman Carbogen Amcis Ltd's P/E is 133.5×, near the high end of its own history: higher than 89% of past readings. Its usual P/E (the middle reading) is 30.6×, over 9.1 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹1.03.

Why the multiple is where it is: over the past year earnings per share moved +2,861.9% while the price moved −37.8%. Earnings did better than the price, which pulled the multiple down within its own range.

Where the price move came from: over 3 years the price moved +1.9% a year; about −16.0% a year came from earnings growth and about +17.9 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple.

Dishman Carbogen Amcis Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.